Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
22.52
-0.92 (-3.92%)
Sep 18, 2026, 4:00 PM EDT - Market closed
Maze Therapeutics Market Cap
Maze Therapeutics has a market cap or net worth of $1.25 billion as of September 18, 2026. Its market cap has increased by 21.39% in one year.
Market Cap
1.25B
Enterprise Value
816.48M
1-Year Change
21.39%
Ranking
Category
Stock Price
$22.52
ChartMarket Cap Chart
Since the IPO on January 31, 2025, Maze Therapeutics's market cap has increased from $685.23M to $1.25B, an increase of 82.56%. That is a compound annual growth rate of 44.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 1.25B | -37.25% |
| Dec 31, 2025 | 1.99B | 190.94% |
| Jan 31, 2025 | 685.23M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ArriVent BioPharma | 1.40B |
| Savara | 1.38B |
| Cullinan Therapeutics | 1.37B |
| LB Pharmaceuticals | 1.36B |
| Omeros | 1.34B |
| ORIC Pharmaceuticals | 1.34B |
| Vor Biopharma | 1.30B |
| Aktis Oncology | 1.27B |